InfuSystems Holdings Inc Market Cap ($165.69 Million)
Market Cap & Net Worth: InfuSystems Holdings Inc (INFU)
InfuSystems Holdings Inc market cap. InfuSystems Holdings Inc (NYSE MKT:INFU) has a market capitalization of $165.69 Million ($165.69 Million) as of October 27, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #17151 globally and #4073 in its home market, demonstrating a 12.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InfuSystems Holdings Inc's stock price $9.66 by its total outstanding shares 20181703 (20.18 Million).
InfuSystems Holdings Inc Market Cap History (2015–2026)
InfuSystems Holdings Inc market cap history from 2015 to 2026. Data shows growth from $60.95 Million to $194.96 Million (11.99% CAGR). Check INFU live share price for real-time trading data and today's change.
InfuSystems Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InfuSystems Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of InfuSystems Holdings Inc for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
1.26x
InfuSystems Holdings Inc's market cap is 1.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.32x
InfuSystems Holdings Inc's market cap is 27.32 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $51.46 Million | $70.50 Million | -$222.00K | 0.73x | N/A |
| 2017 | $46.42 Million | $71.08 Million | -$20.71 Million | 0.65x | N/A |
| 2018 | $69.43 Million | $67.14 Million | -$1.09 Million | 1.03x | N/A |
| 2019 | $172.15 Million | $81.11 Million | $1.36 Million | 2.12x | 126.49x |
| 2020 | $379.01 Million | $97.39 Million | $17.33 Million | 3.89x | 21.87x |
| 2021 | $343.69 Million | $102.38 Million | $1.42 Million | 3.36x | 242.04x |
| 2022 | $175.18 Million | $109.91 Million | $18.00K | 1.59x | 9732.07x |
| 2023 | $212.72 Million | $125.78 Million | $872.00K | 1.69x | 243.94x |
| 2024 | $170.54 Million | $134.86 Million | $2.35 Million | 1.26x | 72.72x |
| 2025 | $181.03 Million | $143.44 Million | $6.63 Million | 1.26x | 27.32x |
Competitor Companies of INFU by Market Capitalization
Companies near InfuSystems Holdings Inc in the global market cap rankings as of October 27, 2026. See debt-free asset ratio of InfuSystems Holdings Inc to understand what proportion of total assets are financed by equity.
Key companies related to InfuSystems Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #120 globally with a market cap of $180.32 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.81 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #120 | Abbott Laboratories | NYSE:ABT | $180.32 Billion | $103.70 |
| #205 | Stryker Corporation | NYSE:SYK | $117.81 Billion | $307.15 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $95.41 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of InfuSystems Holdings Inc (2015–2026)
Market capitalization of InfuSystems Holdings Inc from 2015 to today. Between 2015 and today, InfuSystems Holdings Inc's market cap moved from $60.95 Million to $ 194.96 Million, with a yearly change of 11.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $194.96 Million | +7.69% |
| 2025 | $181.03 Million | +6.15% |
| 2024 | $170.54 Million | -19.83% |
| 2023 | $212.72 Million | +21.43% |
| 2022 | $175.18 Million | -49.03% |
| 2021 | $343.69 Million | -9.32% |
| 2020 | $379.01 Million | +120.16% |
| 2019 | $172.15 Million | +147.97% |
| 2018 | $69.43 Million | +49.57% |
| 2017 | $46.42 Million | -9.80% |
| 2016 | $51.46 Million | -15.56% |
| 2015 | $60.95 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 27th, 2026 the market cap of InfuSystems Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $165.69 Million USD |
| MoneyControl | $165.69 Million USD |
| MarketWatch | $165.69 Million USD |
| marketcap.company | $165.69 Million USD |
| Reuters | $165.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About InfuSystems Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more